退行性颈髓病研究的最小数据集:核心结局集、核心数据元素与核心测量集(AO Spine RECODE DCM):一项共识研究
针对退行性颈髓病(DCM)临床研究结局选择不统一的问题,本研究采用改良德尔菲流程等多阶段共识方法制定最小数据集。最终形成含28个结局、6个域的核心结局集,含32个结局、4个域的核心数据元素,以及包含mJOA、NDI、SF-36v2和SAVES2的核心测量集,并推荐评估手术结局的试验在基线及术后6个月测量。
要点
- 核心结局集含28个结局、6个域:疼痛、神经功能、生活影响、影像学、经济影响和不良事件。
- 核心数据元素含32个结局、4个域:个体、疾病、检查和干预。
- 核心测量集包含mJOA、NDI、SF-36v2和SAVES2四种工具。
核心结论
- AO Spine RECODE-DCM已制定出可用于当前DCM临床试验的最小数据集,可在https://myelopathy.org/minimum-dataset/获取。
- 作者认为核心数据元素和核心结局集具有较强且持久的适用性,但承认新的测量工具以及越来越多地研究未接受手术的患者,可能需要更新和调整,尤其是核心测量集。
研究设计与样本
- 采用一系列改良德尔菲流程制定最小数据集,共9个阶段:建立国际DCM利益相关者小组、形成结局与数据元素长列表并划分域、两阶段德尔菲优先排序、共识会议确定最终最小数据集、最终确定各结局测量构念定义、系统文献综述界定测量工具的心理测量学特性、改良德尔菲流程筛选候选测量工具、共识会议形成最终测量集、整合入模板临床研究表格(CRFs)。
主要发现
- 最终核心结局集纳入28个结局和6个域(疼痛、神经功能、生活影响、影像学、经济影响和不良事件)。
- 最终核心数据元素纳入32个结局和4个域(个体、疾病、检查和干预)。
- 核心测量集确定4种结局工具:mJOA、NDI、SF-36v2和SAVES2。
关键数值与推荐
- 核心测量集推荐评估手术结局的试验在基线及术后6个月测量结局。
局限性
- 作者承认新的测量工具以及越来越多地研究未接受手术的患者,可能需要更新和调整,尤其是核心测量集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Degenerative cervical myelopathy (DCM) is a progressive chronic spinal cord injury estimated to affect 1 in 50 adults. Without standardised guidance, clinical research studies have selected outcomes at their discretion, often underrepresenting the disease and limiting comparability between studies. Utilising a standard minimum data set formed via multi-stakeholder consensus can address these issues. This combines processes to define a core outcome set (COS)-a list of key outcomes-and core data elements (CDEs), a list of key sampling characteristics required to interpret the outcomes. Further "how" these outcomes should be measured and/or reported is then defined in a core measurement set (CMS). This can include a recommendation of a standardised time point at which outcome data should be reported. This study defines a COS, CDE, and CMS for DCM research. METHODS AND FINDINGS: A minimum data set was developed using a series of modified Delphi processes. Phase 1 involved the setup of an international DCM stakeholder group. Phase 2 involved the development of a longlist of outcomes, data elements, and formation into domains. Phase 3 prioritised the outcomes and CDEs using a two-stage Delphi process. Phase 4 determined the final DCM minimal data set using a consensus meeting. Using the COS, Phase 5 finalised definitions of the measurement construct for each outcome. In Phase 6, a systematic review of the literature was performed, to scope and define the psychometric properties of measurement tools. Phase 7 used a modified Delphi process to inform the short-listing of candidate measurement tools. The final measurement set was then formed through a consensus meeting (Phase 8). To support implementation, the data set was then integrated into template clinical research forms (CRFs) for use in future clinical trials (Phase 9). In total, 28 outcomes and 6 domains (Pain, Neurological Function, Life Impact, Radiology, Economic Impact, and Adverse Events) were entered into the final COS. Thirty two outcomes and 4 domains (Individual, Disease, Investigation, and Intervention) were entered into the final CDE. Finally, 4 outcome instruments (mJOA, NDI, SF-36v2, and SAVES2) were identified for the CMS, with a recommendation for trials evaluating outcomes after surgery, to include baseline measurement and at 6 months from surgery. CONCLUSIONS: The AO Spine RECODE-DCM has produced a minimum data set for use in DCM clinical trials today. These are available at https://myelopathy.org/minimum-dataset/. While it is anticipated the CDE and COS have strong and durable relevance, it is acknowledged that new measurement tools, alongside an increasing transition to study patients not undergoing surgery, may necessitate updates and adaptation, particularly with respect to the CMS.
引用
- Davies BM, Yang X, Khan DZ, et al. A minimum data set-Core outcome set, core data elements, and core measurement set-For degenerative cervical myelopathy research (AO Spine RECODE DCM): A consensus study. PLoS Med. 2024. PMID: 39173109. doi:10.1371/journal.pmed.1004447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。